InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,460.48
(
-0.41%
)
US TECH 100
19,181.60
(
-0.43%
)
Dow Jones
39,118.86
(
-0.12%
)
Brent Oil
84.85
(
0.00%
)
Bitcoin
61,642.10
(
1.23%
)
Post# of 252431
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

ghmm

Send PM Follow Ignore
Followers 50
Posts 6343
Boards Moderated 0
Alias Born 01/22/2006

ghmm

Re: ghmm post# 68564

Friday, 11/14/2008 5:00:53 PM

Friday, November 14, 2008 5:00:53 PM

Post# of 252431 
 
 Stock  Product          Stage                   Comments  
  -----  ---------------  ---------------------   -----------------------------  
  NTII   Viprinex         Phase 3                 Interim analysis January '09.  Stroke Drug, high chance of failure.  
  BPAX   Libigel          Phase 3 ~2010 Submit    Adequate Safety?  
  EPIX   Vasovist         PDUFA 12/30/08          FDA initial rejected saying 2 more studies needed.  Allowed reread company states  
                                                  results very positive.  Looking to sell outright on approval.  
  RPRX   Proellex         Phase 3                 Uterine fibroids
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up